Search results
Mar 17, 2015 · PR Newswire. FRANKLIN LAKES, N.J., March 17, 2015 / PRNewswire / -- Becton, Dickinson and Company (NYSE: BDX) ("BD") today announced that it completed its acquisition of CareFusion Corporation ("CareFusion") pursuant to the terms of its previously announced Agreement and Plan of Merger, dated October 5, 2014 (the "Merger Agreement").
CareFusion proudly introduces the comprehensive line of high-quality, clinically-valued anesthesia delivery and patient monitor solutions from Vital Signs ®. Vital Signs product categories include anesthesia consumables, airway access devices, patient monitoring, diagnostic cardiology (DCAR), perinatal monitoring and temperature management ...
CareFusion | 66,288 followers on LinkedIn. CareFusion, a BD company, is a global corporation serving the health care industry with products and services that help improve the cost and safety of...
FRANKLIN LAKES, N.J. and SAN DIEGO, Oct. 5, 2014 /PRNewswire/ -- BD (NYSE: BDX) and CareFusion (NYSE: CFN) announced today a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a total of $12.2 billion, to create a global leader in medication management and patient safety solutions.
CareFusion was a medical company specializing in two areas: reducing medication errors and prevention of health care-associated infections . Spinoff. CareFusion was created in 2009 as a spinoff of medical technology businesses from Cardinal Health. [1] . It began publicly trading on the New York Stock Exchange on September 1, 2009. [2] .
- 2009
- Medical Technology
- Acquired by Becton Dickinson in 2015
- Subsidiary
Oct 6, 2014 · Becton Dickinson to Buy CareFusion: the Next Medtech Megamerger. Nancy Crotti. October 6, 2014. 3 Min Read. In but another sign of consolidation in the medical device industry, Becton Dickinson has announced it will acquire CareFusion for $12.2 billion in cash and stock.
May 17, 2020 · Becton, Dickinson & Co. (NYSE: BDX) recently announced that it will be acquiring the San Diego biomedical business CareFusion (NYSE: CFN) for $12.2 billion. The purchase price is nearly three times CareFusion’s value on its first day of trading, when it closed with a market valuation of $4.2 billion. The deal, expected to close in the first ...
People also ask
What does CareFusion do?
Will bd acquire CareFusion?
Who advised CareFusion?
What's new at CareFusion?
